Document Detail

Rates of change in liver copper concentration in cattle given a copper-deficient diet, with or without pre-treatment with tetrathiomolybdate, for evaluation of two parenteral copper supplements.
MedLine Citation:
PMID:  23013209     Owner:  NLM     Status:  Publisher    
Abstract AIM: To minimise the impact of initial variation in liver copper (Cu) on assessments of Cu supplements for cattle in depletion/repletion experiments. METHODS: Efficacy of two Cu injections was assessed with 18 calves, weighing 200-250 kg, given a Cu-deficient barley diet, containing 4.1 mg Cu/kg dry matter (DM) and added molybdenum (3 mg/kg) and sulphur (3 g/kg). Initial liver biopsy Cu ranged from 3.15-14.17 mmol/kg DM and nine calves with the highest values were given three subcutaneous injections of 235 mg tetrathiomolybdate (TTM) after 42-46 days depletion to lower liver Cu. Untreated (L) and TTM-treated (H) calves were ranked separately for liver Cu after 50 days depletion and allocated to one of three treatments: 100 mg Cu given subcutaneously as CuCaEDTA in either a paraffin (CuP) or aqueous base (CuA) after 56 days depletion (Day 0) or no injection (O). Thereafter, plasma and liver biopsy Cu were measured every 2-4 weeks for 16 weeks. Responses in liver Cu to Cu injections were compared with and without log(e) transformation and by linear regression. RESULTS: Prior to Cu injection, the fractional decline in liver Cu concentration (FDLCu) after 50 days depletion was 0.64 (SE 0.066) and 0.80 (SE 0.090) in H and L calves, respectively (p=0.09) and mean liver Cu did not differ on Day -6 (6.65 (SE 0.516) and 4.91 (SE 0.681) mmol/kg DM, respectively). Mean plasma Cu was higher in H than L calves on Day 0 (16.6 (SE 0.52) and 13.3 (SE 0.49) μmol/L, respectively (p<0.001)). Rates of decline in log(e) liver Cu between Days 0-84 in treatments L and H were: 0.0138 and 0.0071 for Groups O; 0.0033 and 0.0016 for Groups CuP; 0.0073 and 0.0049 for Groups CuA (pooled SE 0.0014) mmol/kg DM/day, respectively. Between Days 84-114, FDLCu was uniformly high across experiments and groups (0.59 (SE 0.042)). Cu injections did not affect plasma Cu, which remained 3.1 (SE 0.41) umol/L higher in Experiment H than in L (p=0.017). CONCLUSIONS: The use of rates of change in liver copper concentrations improved the assessment of efficacy for two parental copper supplements and that of pre-treatment with tetrathiomolybdate, which, contrary to expectation, slowed Cu turnover by mechanisms that remain unclear.
Nf Suttle
Related Documents :
7909049 - Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.
1568329 - Micral-test strips evaluated for screening for albuminuria.
3110729 - Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea o...
17124849 - Theophylline does not potentiate the effects of a low dose of dexamethasone in horses w...
1950539 - Kinetic profile of miocamycin in middle ear fluid and mucosa.
2119459 - Safety and metabolic effects of l-glutamine administration in humans.
16198549 - Contribution of lymphatic transport to the systemic exposure of orally administered mox...
4024029 - A human pharmacological study comparing conventional heparin and a low molecular weight...
2073589 - Blockade of cck-b receptors by l-365,260 induces analgesia in the squirrel monkey.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-27
Journal Detail:
Title:  New Zealand veterinary journal     Volume:  -     ISSN:  0048-0169     ISO Abbreviation:  N Z Vet J     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0021406     Medline TA:  N Z Vet J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
a Moredun Foundation, Pentlands Science Park , Penicuik , EH26 0PZ , UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetics of 450?mg ropivacaine with and without epinephrine for combined femoral and sciatic...
Next Document:  Percutaneous injuries amongst Greek endodontists: a national questionnaire survey.